Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. - Wikidata - awgldk - TriplyDB

Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial.

Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial.

http://www.wikidata.org/entity/Q34447997

about

Non-hormonal interventions for hot flushes in women with a history of breast cancer Management of hot flashes in women with breast cancer American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline Menopausal symptoms in young survivors of breast cancer: a growing problem without an ideal solution Adverse effects of non-hormonal pharmacological interventions in breast cancer survivors, suffering from hot flashes: A systematic review and meta-analysis Advances in the treatment of menopausal symptoms.Randomised controlled trial comparing hypnotherapy versus gabapentin for the treatment of hot flashes in breast cancer survivors: a pilot study.How are Interactions Taken into Account in Studies on Conventional and Complementary Therapies for Breast Cancer Patients with Menopausal Complaints?Can alternative medicine do better than placebo?: Does it even matter?Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1 Update in new medications for primary care.Comparison of Gabapentin with Estrogen for treatment of hot flashes in post-menopausal women Coprescription of tamoxifen and medications that inhibit CYP2D6.Effects of stellate ganglion block on vasomotor symptoms: findings from a randomized controlled clinical trial in postmenopausal women A2delta ligands gabapentin and pregabalin: future implications in daily clinical practice.Caring for the breast cancer survivor's health and well-being.Gabapentin vs. low-dose transdermal estradiol for treating post-menopausal women with moderate to very severe hot flushes.Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions.Feeling too hot or cold after breast cancer: is it just a nuisance or a potentially important prognostic factor?Unjustified prescribing of CYP2D6 inhibiting SSRIs in women treated with tamoxifen.Management of complications of androgen deprivation therapy in the older man.Breast cancer survivorship issues.Pilot evaluation of a stellate ganglion block for the treatment of hot flashes.A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: a review.Safety and efficacy of gabapentin in management of psychosomatic and sexual symptoms in postmenopausal women: A pilot study.A randomized, controlled, double-blinded clinical trial of gabapentin 300 versus 900 mg versus placebo for anxiety symptoms in breast cancer survivors.Hot flashes: a review of pathophysiology and treatment modalities.Is complementary and alternative therapy effective for women in the climacteric period?Nighttime awakenings responding to gabapentin therapy in late premenopausal women: a case series.Androgen deprivation therapy-associated vasomotor symptoms Treatment options for vasomotor symptoms in menopause: focus on desvenlafaxine.Design of a randomized controlled trial of Internet-based cognitive behavioral therapy for treatment-induced menopausal symptoms in breast cancer survivors Electroacupuncture Versus Gabapentin for Hot Flashes Among Breast Cancer Survivors: A Randomized Placebo-Controlled Trial Acupuncture for hot flashes: decision making by breast cancer survivors.The effect of gabapentin on intensity and duration of hot flashes in postmenopausal women: a randomized controlled trial.Safety of alternative treatments for menopausal symptoms after breast cancer: a qualitative systematic review.Risk factors, pathophysiology, and treatment of hot flashes in cancer.Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions The unique challenges of managing depression in mid-life women

P2860

Q24235391-65D1DFAF-A5AB-4DA1-B5E6-A632D93969C7 Q24644229-21D77051-C9FC-4ED1-AB41-B9CC84FF595F Q26773986-3BE3A0F0-11A5-4719-BFE7-82DE0FA77F2D Q27025094-6746170D-1CE1-47DC-92BA-0C7AD7BD9CC1 Q28076663-F1EFAA19-ADB1-4A77-B24B-394FE61CC412 Q30448720-AD3D4CBE-ED87-4192-8D8F-E9B6F5367931 Q30544854-F45BE21D-3B20-4DDA-96AF-88E9974BEEDE Q33579094-C9309F1D-EEB7-4C77-ADF9-BED610686D93 Q33613065-525040F2-FD7B-4CCE-8F92-1EED21845986 Q33628788-76559D3E-D021-4F10-BD35-3E90E85BE5A1 Q33730845-3032178E-373D-4A7C-B577-0C98EAE86DC6 Q33828000-F92B43E6-582F-4DC9-A4DE-5378DA4E485A Q33898184-34F444B3-34D3-4CB6-B56A-ACEB19CD51B4 Q33946509-8B6FF55A-ED0F-4BD5-87AF-128B481A8258 Q33953965-5EE9C9A4-36F7-4851-82A1-668376158216 Q34031251-30C99A6E-87D0-4509-9E89-768AAB99FB73 Q34091082-8DEBED25-AF6B-4616-906C-32C39E2E330B Q34272132-2893FBA2-A892-4420-83C1-A6D4DC7422B1 Q34449535-29152A2B-DA54-411D-9116-EA545ABE3EEF Q34768999-F02B9980-87CC-4D55-B271-C3CBDAD4017C Q34782101-795096A1-1498-4C38-AA9C-8E7E755B2D44 Q34895561-4A58E835-613D-4C10-A234-45E4F1377842 Q35022143-D9134D6D-E5C3-4998-889F-978D2BA7B3D4 Q35092002-EC89A6A4-39DF-47D6-9181-F66611EFE04C Q35143365-DBAC0CDD-BA29-4E24-A039-E55333FE77F5 Q35313740-241852B9-E180-4260-BFAF-E113A380D627 Q35545279-1E8CDF9F-E5FE-44DE-80A7-F40CFE4B1E6E Q35599841-A6612CB4-4B29-484F-B27F-F0CAFA86B3F1 Q35675788-26AC414C-3764-4D65-BCC5-38670F9F1B00 Q35849901-2E88C86A-1B9D-47E1-AE41-1C13EAD31746 Q35917204-5694F84D-2290-47F5-8614-30C033BBCCE7 Q36136356-61204487-DC1B-4878-B454-9FDF5C9F86D6 Q36204133-609765F1-0D30-42E2-A77A-05C4822502A8 Q36211612-CCB3A3E4-81BF-4B0B-ABDB-BE30A0F6E782 Q36374818-B01D822A-C185-4605-805F-D746DA1E8E27 Q36647827-46684EA4-51E1-41F5-B166-B729EC6390D6 Q36761448-845FF928-803C-494D-B8F5-E91A8C3CBF95 Q36807455-DF343D27-8451-403A-B200-2A4EB93B494C Q36818466-497D6F8C-02A5-413E-B691-2A3C6F8AB493 Q36919943-AF5AEAD0-51A1-425D-91BF-912DCAE0CA99

P2860

Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial.

http://www.wikidata.org/entity/Q34447997

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Gabapentin for hot flashes in ...... lind placebo-controlled trial.

@ast

Gabapentin for hot flashes in ...... lind placebo-controlled trial.

@en

Gabapentin for hot flashes in ...... lind placebo-controlled trial.

@nl

type

label

Gabapentin for hot flashes in ...... lind placebo-controlled trial.

@ast

Gabapentin for hot flashes in ...... lind placebo-controlled trial.

@en

Gabapentin for hot flashes in ...... lind placebo-controlled trial.

@nl

prefLabel

Gabapentin for hot flashes in ...... lind placebo-controlled trial.

@ast

Gabapentin for hot flashes in ...... lind placebo-controlled trial.

@en

Gabapentin for hot flashes in ...... lind placebo-controlled trial.

@nl

P1433

Q34447997-E85E08BE-5E20-49C9-B435-A1ECA844FC16

P1476

Q34447997-9F55DCA8-A7E7-44D0-AAE2-9146B4E3FAA6

P2093

Q34447997-03011828-905E-4C80-AF42-19FA2B9D7C3E

Q34447997-5D61A292-C7F9-4A91-B2E0-1425DFE448E2

Q34447997-5E5F4762-4077-44E8-AA61-B152B872B977

Q34447997-7154DA7D-52D6-4A11-A80E-D64DF7AD0877

Q34447997-8F21467D-AE2D-4F8E-8B53-1DAD2402620C

Q34447997-C345A6AF-9995-46F2-AEAB-01B50CCA0481

Q34447997-C3AAEF50-8FCA-4EFA-9BEC-84BB2A7074A6

Q34447997-E1D1494F-5B12-45A4-B185-1A9B8B5962A1

Q34447997-E8FE618E-ADA9-45FB-899C-2FECC65A442A

P2860

Q34447997-1B8ECA69-777F-4B00-8AE2-24CD685DFE3D

Q34447997-1D2319E4-612E-4645-967C-052FB944D1D3

Q34447997-24FF8692-1547-4C0C-A647-F3358E5155BB

Q34447997-255862C5-C0A2-4F1C-8FE5-932485A4BED4

Q34447997-2771E131-CB9C-49EA-856F-62CD93061E94

Q34447997-2833C3EE-23E0-485C-81F0-19F0B324A214

Q34447997-2E11C9BF-89A9-4E31-A5D6-B945A1276996

Q34447997-3CDF466F-A3E4-4E2D-BA60-7F9ED1CF315F

Q34447997-3F07795A-71C5-4F91-A06E-B3D8C0A0D1F6

Q34447997-4BC4D5F1-F20D-4460-9ACE-DB97F91C4754

P304

Q34447997-1BEF05A2-B9C5-4770-8170-864DA8BD835E

P31

Q34447997-46173FD3-C0AC-41DF-86C4-191FF1E32D47

P356

Q34447997-ACEBBEC7-84C5-4255-B822-13B6E2EB0E83

P407

Q34447997-5E4E5246-392D-4FC6-9812-BE576C6B7D4D

P433

Q34447997-D4199AC3-36C7-4AFD-AA66-3D84F513FE43

P478

Q34447997-FC863BF4-135F-4312-81BC-3BF0212BCF9F

P577

Q34447997-D2C890EA-D955-47C5-9182-70B66B6979EE

P5875

Q34447997-DD19BC1E-248E-4113-B949-8A4D73D09AFD

P698

Q34447997-4DAB0E82-B676-4705-B5E4-8AAC55A38896

P921

Q34447997-4D2204A0-46C7-4D06-BF53-66F2D841D9BE

Q34447997-5268B42B-1F28-4BAB-8162-3AC22D237E51

P932

Q34447997-65850C75-6D3B-413B-9BA3-C9A00F17EDB7

P356

S0140-6736(05)67215-7

P1433

P1476

Gabapentin for hot flashes in ...... lind placebo-controlled trial.

@en

P2093

Eduardo Pajon

http://www.w3.org/2001/XMLSchema#string

Gary R Morrow

http://www.w3.org/2001/XMLSchema#string

Hongwei Zhao

http://www.w3.org/2001/XMLSchema#string

Jane T Hickok

http://www.w3.org/2001/XMLSchema#string

Joseph A Roscoe

http://www.w3.org/2001/XMLSchema#string

Kishan J Pandya

http://www.w3.org/2001/XMLSchema#string

Patrick J Flynn

http://www.w3.org/2001/XMLSchema#string

Tarit K Banerjee

http://www.w3.org/2001/XMLSchema#string

Thomas J Sweeney

http://www.w3.org/2001/XMLSchema#string

P2860

Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss.

Pathophysiology and treatment of hot flashes.

Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial.

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.

Estrogen and cancer.

The menopausal syndrome

Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial.

Thermoregulatory physiology of menopausal hot flashes: a review.

Hypothesis: pathogenesis of postmenopausal hot flush.

The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel.

P304

818-824

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0140-6736(05)67215-7

http://www.w3.org/2001/XMLSchema#string

P407

P433

9488

http://www.w3.org/2001/XMLSchema#string

P478

366

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7620976

http://www.w3.org/2001/XMLSchema#string

P698

16139656

http://www.w3.org/2001/XMLSchema#string

P921

P932

1627210

http://www.w3.org/2001/XMLSchema#string